» Articles » PMID: 33623893

Cardiovascular Disease Risk Prediction for People with Type 2 Diabetes in a Population-based Cohort and in Electronic Health Record Data

Overview
Journal JAMIA Open
Date 2021 Feb 24
PMID 33623893
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Electronic health records (EHRs) have become a common data source for clinical risk prediction, offering large sample sizes and frequently sampled metrics. There may be notable differences between hospital-based EHR and traditional cohort samples: EHR data often are not population-representative random samples, even for particular diseases, as they tend to be sicker with higher healthcare utilization, while cohort studies often sample healthier subjects who typically are more likely to participate. We investigate heterogeneities between EHR- and cohort-based inferences including incidence rates, risk factor identifications/quantifications, and absolute risks.

Materials And Methods: This is a retrospective cohort study of older patients with type 2 diabetes using EHR from New York University Langone Health ambulatory care (NYULH-EHR, years 2009-2017) and from the Health and Retirement Survey (HRS, 1995-2014) to study subsequent cardiovascular disease (CVD) risks. We used the same eligibility criteria, outcome definitions, and demographic covariates/biomarkers in both datasets. We compared subsequent CVD incidence rates, hazard ratios (HRs) of risk factors, and discrimination/calibration performances of CVD risk scores.

Results: The estimated subsequent total CVD incidence rate was 37.5 and 90.6 per 1000 person-years since T2DM onset in HRS and NYULH-EHR respectively. HR estimates were comparable between the datasets for most demographic covariates/biomarkers. Common CVD risk scores underestimated observed total CVD risks in NYULH-EHR.

Discussion And Conclusion: EHR-estimated HRs of demographic and major clinical risk factors for CVD were mostly consistent with the estimates from a national cohort, despite high incidences and absolute risks of total CVD outcome in the EHR samples.

Citing Articles

Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis.

Ahmad A, Lim L, Morieri M, Tam C, Cheng F, Chikowore T Commun Med (Lond). 2024; 4(1):11.

PMID: 38253823 PMC: 10803333. DOI: 10.1038/s43856-023-00429-z.


Evaluation of available risk scores to predict multiple cardiovascular complications for patients with type 2 diabetes mellitus using electronic health records.

Ho J, Staimez L, Narayan K, Ohno-Machado L, Simpson R, Hertzberg V Comput Methods Programs Biomed Update. 2023; 3.

PMID: 37332899 PMC: 10274317. DOI: 10.1016/j.cmpbup.2022.100087.


Developing a Data Quality Standard Primer for Cardiovascular Risk Assessment from Electronic Health Record Data Using the DataGauge Process.

Diaz-Garelli F, Long A, Bancks M, Bertoni A, Narayanan A, Wells B AMIA Annu Symp Proc. 2022; 2021:388-397.

PMID: 35308992 PMC: 8861746.


Willingness-to-pay for cancer treatment and outcome: a systematic review.

Sze Jing Yong A, Lim Y, Cheong M, Hamzah E, Teoh S Eur J Health Econ. 2021; 23(6):1037-1057.

PMID: 34853930 DOI: 10.1007/s10198-021-01407-9.

References
1.
Pylypchuk R, Wells S, Kerr A, Poppe K, Riddell T, Harwood M . Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study. Lancet. 2018; 391(10133):1897-1907. DOI: 10.1016/S0140-6736(18)30664-0. View

2.
Balfour Jr P, Ruiz J, Talavera G, Allison M, Rodriguez C . Cardiovascular Disease in Hispanics/Latinos in the United States. J Lat Psychol. 2016; 4(2):98-113. PMC: 4943843. DOI: 10.1037/lat0000056. View

3.
Shah A, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale C . Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1·9 million people. Lancet. 2015; 385 Suppl 1:S86. DOI: 10.1016/S0140-6736(15)60401-9. View

4.
Goldstein B, Bhavsar N, Phelan M, Pencina M . Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record. Am J Epidemiol. 2016; 184(11):847-855. PMC: 5152663. DOI: 10.1093/aje/kww112. View

5.
Shah A, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale C . Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2014; 3(2):105-13. PMC: 4303913. DOI: 10.1016/S2213-8587(14)70219-0. View